Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers.

The article discusses the study that aims to evaluate the value of fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment contrast-enhanced computed tomography/magnetic resonance imaging in evaluating the ablative safety margin after percutaneous ultrasound guided radiofrequency ablation (RFA) for liver cancers. It states that all methods are effective in evaluating the ablative safety margin early after RFA.